O-I Glass, Inc., through its subsidiaries, manufactures and sells glass containers to food and beverage manufacturers primarily in the Americas, Europe, and the Asia Pacific. The company produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. It is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. In addition, the company offers glass containers in a range of sizes, shapes, and colors. It sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. The company was founded in 1903 and is headquartered in Perrysburg, Ohio.

O-I Glass, Inc.

Glass Health

Glass Health is thrilled to announce our $5M seed round led by Initialized Capital. 🎉

Our latest funding will further our mission to empower clinicians with generative AI for clinical decision support.

We’re proud to count prominent healthcare founders as mentors and investors in this seed round, including Tom Lee, founder of One Medical, Epocrates, and Galileo Health; Connor Landgraf, founder of Eko Health; and Heather Hasson & Trina Spear, the co-founders of FIGS.

https://lnkd.in/gfA9xW6w

#Y Combinator #Breyer Capital #Initialized Capital

Our Glass AI CDS platform has been upgraded with a new core feature...🥁🎁

Glass Consult is our NEW clinical reference chatbot✨

Consult uses physician-validated context to answer clinical reference questions with in-text references at glass.health🎊🦾

Check out Glass Consult in action above, featuring physician-validated context on Acute Appendicitis by Glass Health AI Clinical Fellows & AI Editors, Marianne Ruelle, MD; Deven Patel, MD; & Gurbani Kaur, MD

#AI #AICDS #healthcareinnovation #healthcaretechnology #aiinhealthcare 

Y Combinator Initialized Capital

Tomorrow is almost here...

#healthcareinnovation #ai #healthcare #healthcaretechnology #AICDS

Introducing History & Physical Mode! 

Clinicians, we heard your request for better handling of complex cases by Glass AI. Starting today, you can input a full H&P to draft AI-assisted differential diagnoses and clinical plans. 

Try H&P Mode now at http://glass.health

This update includes major upgrades to the Glass user interface and its ability to assist with differential diagnosis and clinical plan drafting. Clinical training of Glass AI is ongoing by the Glass Health team of academic clinical contributors.

Glass AI is an experimental product in development. Given ongoing development and LLM limitations, all AI results should be supervised at the level of a trainee, interpreted cautiously, and should never replace clinician knowledge or judgment.

#healthcareinnovation #ai #aiinhealthcare Y Combinator

Glass Health's mission to empower clinicians with AI-assisted diagnosis and clinical decision-making is featured in this recent piece by the World Economic Forum 🏥 

https://lnkd.in/ehQa48Mk

🎊 New Updates to Glass AI🎊

The Glass Health team has trained Glass AI to draft clinical plans for new topics!

Check out our new handling of...
- hypoxemia
- hemoptysis
- community-acquired PNA

We're also sharpening Glass AI's ability to develop a DDx for high-yield medicine topics, including:

- hypoxemia
- constipation
- TIA
- UTI.

Just try entering a one-liner at http://glass.health. Glass AI will suggest 5 potential diagnoses to consider.

#ai #healthcare #healthtech #medicine Y Combinator Dereck Paul, MD Graham Ramsey

🚨 NEW Version of Glass AI Available 🚨 

Glass AI 2.0 combines an LLM with a clinical knowledge database created by our clinician team.

With clinician training, we create better DDx and Clinical Plan outputs than base LLMs.

Try 2.0 now at http://glass.health/ai

Clinicians have trained Glass AI 2.0 for this first release on a select group of high-yield medical topics.

Training is ongoing and you can view the full list of medical topics included in this release within the product.

Glass AI is in development to assist clinicians with differential diagnosis, evidence-based Tx, and documentation.

We make advances with your feedback and thank the community who has used Glass AI 1.0 over the past few weeks.

Please remember, Glass AI is a reference tool and assistant, like a smart textbook. It does not replace clinician judgment and should always be supervised.

Notably, Glass AI was not created for the general public and does not generate general advice medical advice.

Today's release of Glass AI 2.0 is the collective effort of the incredible Glass AI Clinical Contributor team. Full credits within the Glass AI tab in the Glass platform.

cc: Dereck Paul, MD, Graham Ramsey, Y Combinator, Breyer Capital

msh id	COM:O-I
symbol	OI
name	O-I Glass, Inc.
homepage url	https://www.o-i.com
country	US
sector	Consumer Cyclical
industry	Packaging & Containers
market	STOCKS
employee count	23K
crunchbase url	-
linkedin url	-
founders	-

market cap	1.64B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0
growth cost of revenue	-0.01
growth depreciation and amortization	-1
growth ebitda	-0.43
growth ebitda ratio	-0.45
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	0.23
growth gross profit ratio	0.19

COM:O-I

Glass Health

Last Close

12.56

21/11 21:00

Market Cap

1.64B

Beta: -

Volume Today

848.62K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	6.24B
cost of revenue	6.24B
depreciation and amortization	-
ebitda	864M
ebitda ratio	0.12
eps	1.42
eps diluted	1.42
operating expenses	632M
operating income	864M
operating income ratio	0.12

accounts receivables	151M
capital expenditure	-688M
cash at beginning of period	773M
cash at end of period	913M
inventory	1.07B
working capital ttm	829M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-